23 Nov
A daily dose of an oral antiretroviral drug, currently approved to treat HIV infection, reduced the risk of acquiring HIV infection by 43.8 percent among men who have sex with men. The findings, a major advance in HIV prevention research, come from a large international clinical trial published online Nov. 23 by the New England Journal of Medicine. The study, titled “Chemoprophylaxis for HIV Prevention in Men,” found even higher rates of effectiveness, up to 72.8 percent, among those participants who adhered most closely to the daily drug regimen.
Posted in Clinical Research News by: Tobin C. Guarnacci
No Comments
12 Nov
BANGKOK, 5 November 2010 (IRIN) – Health experts in Thailand say the odds are stacked against them in combating one of the highest HIV prevalence rates in Asia, with only 2 percent of the country’s AIDS budget going on condoms.
Posted in Clinical Research News by: Tobin C. Guarnacci
No Comments
12 Nov
http://www.cdc.gov/hiv/idu/resources/slides/slides/idu.ppt Slide 1 HIV Surveillance in Injection Drug Users (IDU) PDF File or PPT File Slide 2 Diagnoses of HIV Infection among Adults and Adolescents, by Transmission Category, 2005–2008—37 States and 5 U.S. Dependent Areas PDF File or PPT File Slide 3 Diagnoses of HIV Infection among Adults and Adolescents, by Sex and Transmission Category, 2008 —37 [...]
Posted in Clinical Research News by: Tobin C. Guarnacci
No Comments
12 Nov
Miami-Dade health officials announced the first locally acquired case of dengue fever in decades. They also warned about Eastern Equine Encephalitis, cholera — and hookworm on Miami Beach sands.
Read more: http://www.miamiherald.com/2010/11/11/1921775/1-case-of-dengue-fever-reported.html#ixzz155y9rIhW
Posted in Clinical Research News by: Tobin C. Guarnacci
No Comments
24 Aug
A federal district judge on Monday blocked President Obama’s 2009 executive order that expanded embryonic stem cell research, saying it violated a ban on federal money being used to destroy embryos.
Posted in Clinical Research News by: Tobin C. Guarnacci
No Comments
03 Aug
Scientists have genetically tweaked a virus to fashion a therapeutic vaccine that appears to attack a variety of advanced cancers.
Posted in Clinical Research News by: Tobin C. Guarnacci
No Comments
02 Aug
new study suggests that consuming specific compounds in meat related to processing methods may be associated with an increased risk of developing bladder cancer. Published early online in CANCER, a peer-reviewed journal of the American Cancer Society, the findings may be relevant for understanding the role of dietary exposures in cancer risk.
Posted in Clinical Research News by: Tobin C. Guarnacci
No Comments
28 Jul
In 2008, CDC estimated that approximately 56,300 people were newly infected with HIV in 20061 (the most recent year that data are available). Over half (53%) of these new infections occurred in gay and bisexual men. Black/African American men and women were also strongly affected and were estimated to have an incidence rate than was 7 times as high as the incidence rate among whites. Visit the HIV incidence page for more details.
1Hall HI, Ruiguang S, Rhodes P, et al. Estimation of HIV incidence in the United States. JAMA. 2008;300:520-529.
Posted in Clinical Research News by: Tobin C. Guarnacci
No Comments
23 Jun
The CAPA process provides the auditor and auditee with a structured method for the investigation and the follow-up, and resolution of issues identified during the audit process. The CAPA process also serves to provide supporting evidence of audit finding closure and subsequent closure of the audit cycle.
Posted in Clinical Research News by: Tobin C. Guarnacci
No Comments
17 Jun
researchers have discovered two powerful new antibodies to HIV that reveal what may be an Achilles heel on the virus. The findings are the result of a worldwide effort launched by IAVI in 2006 to find new antibodies that neutralize a wide variety of strains of HIV circulating in the world. The study was published in the journal Science.
http://www.iavi.org/research-development/IAVI-RD-Programs/Pages/NewAntibodiesFoundthatCrippleHIV.aspx
Posted in Clinical Research News by: Tobin C. Guarnacci
No Comments